The interactome of the influenza A virus polymerase in replication

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: 2761529

Grant search

Key facts

  • Disease

    Unspecified
  • Start & end year

    2021
    2025
  • Known Financial Commitments (USD)

    $0
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    N/A

  • Research Location

    United Kingdom
  • Lead Research Institution

    Imperial College London
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The aim of this work is to identify host factors specifically involved in IAV replication. As influenza virus is able to rapidly adapt to overcome therapeutics that target viral proteins, host factors act as good targets for the development of anti-influenza drugs. Consequently, this work may suggest new therapeutic targets to treat influenza virus infection, while aiding our understanding of IAV replication and the host determinants of viral pathogenicity. In turn, the tools developed in this work may also be used to further understand host determinants of IAV species specificity. Given the mechanistic differences between transcription and replication and the existence of host factors that are specifically supportive of replication (such as ANP32), we hypothesise that additional host factors exist that are for replication only.